Transforming PCI with the DESolve novolimus-eluting scaffold platforms

Chairpersons: Jean FAJADET, Arif AL NOORYANI, Mohammad KURDI


To understand the possible additional benefits of the use of DESolve for your patients
To learn and discuss the 3-year follow up of patients treated with DESolve
To gain insight on the performance of DESolve in a broader clinical practice


Session objectives

J. Fajadet

DESolve scaffold characteristics and DESolve NX 3-year clinical and imaging result

H. Nef

United Arab Emirates case presentation — Novolimus eluting bioresorbable coronary scaffold system case presentation

A. Al Nooryani

Kingdom of Saudi Arabia case presentation

F. Al Mutairi

Bahrain case presentation — Transforming PCI with DESolve Novolimus eluting platforms

H. Amin

Turkey case presentation — BRS implantation in a bifurcation related CTO lesion

Ö. Göktekin

Key learnings

J. Fajadet


More from Elixir Medical

Visit website